Photo of Steve Scalise
R United States House · District 1 · Louisiana On the 2026 ballot

Rep. Steve Scalise

Compare
Total votes
2,837
all sessions
Attendance
94%
169 missed
Near the chamber average
With party
97%
of cast votes
Higher than 89% of chamber peers
Bipartisan score
2%
crosses aisle rarely
Lower than 90% of chamber peers
Sponsored
143
bills & resolutions
Among the lowest in the chamber
Committees
0
assignments
143 bills and resolutions

Sponsored bills

Total
143
Primary
24
Co-sponsor
119
This page
143
matching current filters
Co-sponsor HRES 850
In committee · United States House · Co-sponsor
Expressing the sense of the House of Representatives that the symbols and traditions of Christmas should be protected for use by those who celebrate Christmas.

This resolution recognizes the importance of Christmas symbols and traditions. The resolution (1) disapproves of attempts to ban references to Christmas, and (2) supports the use of these symbols and traditions by those who celebrate Christmas.

In committee Dec 14, 2021 1 co-sponsor
Co-sponsor HR 6235
In committee Dec 10, 2021 1 co-sponsor
Co-sponsor HR 6056
In committee · United States House · Co-sponsor
Parents Bill of Rights Act

Parents Bill of Rights Act This bill outlines various rights of parents and guardians regarding the elementary or secondary school education of their children. Among other requirements, the bill (1) directs local educational agencies to publicly post the curriculum for each elementary and secondary school grade level; and (2) requires schools to notify parents and guardians of their rights, including the right to review the school's curriculum and budget.

In committee Nov 19, 2021 1 co-sponsor
Co-sponsor HJRES 65
In committee · United States House · Co-sponsor
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to "COVID-19 Vaccination and Testing; Emergency Temporary Standard".

This joint resolution nullifies a Department of Labor emergency temporary standard for preventing the transmission of COVID-19 in employment settings. Under the standard issued on November 5, 2021, employers with 100 or more employees must require their onsite employees to either be fully vaccinated against COVID-19 or undergo weekly COVID-19 testing.

In committee Nov 17, 2021 1 co-sponsor
Primary HR 3919
Signed into law · United States House · Lead sponsor
Secure Equipment Act of 2021

Secure Equipment Act of 2021 This bill requires the Federal Communications Commission (FCC) to establish rules stating that it will no longer review or approve any authorization application for equipment that is on the list of covered communications equipment or services. (Listed communications equipment or services are those that the FCC determines pose an unacceptable risk to national security or the security and safety of U.S. persons.)

Signed into law Nov 11, 2021 0 co-sponsors
Co-sponsor HRES 386
In committee · United States House · Co-sponsor
Expressing support for recognizing "National Police Week".

Maddy summaryHRES 386 is a symbolic resolution introduced in the U.S. House of Representatives that expresses support for recognizing "National Police Week" each year. The resolution acknowledges law enforcement officers' sacrifices, particularly during the pandemic, and encourages the public to honor their service. As a non-binding statement, this resolution does not create new law or change policy but serves as a formal expression of support for law enforcement officers across the United States.

In committee Nov 9, 2021 1 co-sponsor
Co-sponsor HR 5735
In committee · United States House · Co-sponsor
State, Local, Tribal, and Territorial Fiscal Recovery, Infrastructure, and Disaster Relief Flexibility Act

State, Local, Tribal, and Territorial Fiscal Recovery, Infrastructure, and Disaster Relief Flexibility Act This bill allows states, tribes, territories, and localities to use certain COVID-19 relief funds for new categories of spending, including for natural disasters and infrastructure projects. It also makes changes to expenditure deadlines and other aspects of this funding. Specifically, recipients may use funds for emergency relief from natural disasters and associated negative economic impacts of natural disasters. In addition, recipients may use a portion of their COVID-19 relief funds for designated infrastructure projects, such as nationally significant freight and highway projects. Furthermore, the bill allows recipients to expend COVID-19 relief funds on these types of infrastructure projects until September 30, 2026. Under current law, recipients must expend the funds by December 31, 2024. Other changes in the bill include (1) modifying eligibility and allocation requirements for funding set aside for counties and Indian tribes that are near public lands, (2) allowing Indian tribes an additional year to expend their COVID-19 relief funds, and (3) establishing a process for government entities to decline COVID-19 relief funds and requiring any declined funds to be used to reduce the federal deficit.

In committee Oct 26, 2021 1 co-sponsor
Co-sponsor HR 19
In committee · United States House · Co-sponsor
Lower Costs, More Cures Act of 2021

Lower Costs, More Cures Act of 2021 This bill establishes and modifies several programs and requirements to address prescription drug prices. The bill modifies provisions under Medicare and Medicaid relating to prescription drug coverage and price transparency. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies; caps annual out-of-pocket spending under the Medicare prescription drug benefit; allows prescription drug plan sponsors under the Medicare prescription drug benefit to offer additional plans in a region; requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid; and allows states to include in the Medicaid Drug Rebate Program covered outpatient drugs that are provided as part of physician or outpatient hospital services. The bill also generally modifies other provisions relating to the regulation and costs of generic and brand-name drugs. Among other changes, the bill prohibits the manufacturer of a brand-name, generic, or biosimilar drug from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product; permanently allows high deductible health plans to waive deductibles for insulin and associated products; and establishes the position of Chief Pharmaceutical Negotiator in the Office of the U.S. Trade Representative.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2718
In committee · United States House · Co-sponsor
Maximum Pressure Act

Maximum Pressure Act This bill expands sanctions and economic penalties on Iran. It also restricts the President from unilaterally lifting or waiving the sanctions or penalties and increases congressional oversight of them. Specifically, the bill requires the President to impose visa- and asset-blocking sanctions. Additionally, it modifies existing sanctions, including by (1) providing statutory authority for executive orders imposing sanctions; (2) applying sanctions to additional sectors of Iran's economy; and (3) broadening sanctionable conduct to cover, for example, assisting Iran with the acquisition of ballistic missiles and the complicity of Iranian officials in human rights violations in specified countries. The bill also requires reporting on licenses that authorize activities subject to sanctions. The bill prohibits U.S. representatives at the International Monetary Fund from voting to allow Iran's access to special drawing rights (a currency support tool) and places restrictions on financial transactions with Iran. The restrictions include requiring domestic financial institutions to implement special measures with respect to foreign financial institutions that conduct significant transactions connected to the Instrument in Support of Trade Exchanges (a European mechanism that bypasses U.S. sanctions when carrying out trade with Iran). The Department of State must maintain the Islamic Revolutionary Guard Corps' designation as a terrorist organization and must designate Ansharallah (or Houthis), which operates in Syria, as a foreign terrorist organization. The bill also requires reports on U.S. sanctions concerning Iran, the status of Iran's nuclear weapons program, and other matters.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 5586
In committee · United States House · Co-sponsor
Prohibiting IRS Financial Surveillance Act

Prohibiting IRS Financial Surveillance Act This bill prohibits the Department of the Treasury from requiring a financial institution to report the transfers into and out of a financial account. This prohibition does not apply to laws or regulations in effect on October 1, 2021.

In committee Oct 15, 2021 1 co-sponsor
Showing 91 to 100 of 143 bills
Previous 1 … 9 10 11 … 15 Next